Alexandros S.
- Country
- Greece
- Department
- Division of Hematology, Department of Internal Medicine
Research Overview
- Phase II Study of Daratumumab with Bortezomib-Cyclophosphamide-Dexamethasone vs. Bortezomib-Thalidomide-Dexamethasone in Transplant-Eligible Multiple Myeloma Patients
- Phase 2 Evaluation of Isatuximab, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Post-Lenalidomide and Proteasome Inhibitor Therapy
- Phase 2 Evaluation of Isatuximab with Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma with Severe Renal Impairment
Data & Insights
Has run more than one trial at 13 of 82 partner sites.
Specializations
Multiple Myeloma Treatment Innovation
The investigator specializes in developing therapeutic strategies for multiple myeloma, with particular emphasis on newly diagnosed cases and treatment-resistant forms of the disease.
- Novel combination therapies for multiple myeloma
- Treatment approaches for transplant-eligible patients
- Management of refractory disease
Their research encompasses innovative treatment protocols incorporating immunotherapy agents and established therapeutic compounds.
Specialized Patient Populations
The investigator focuses on developing targeted treatments for specific multiple myeloma patient subgroups, including those with severe renal impairment and patients ineligible for stem cell transplantation.
- Renal complications in multiple myeloma
- Treatment strategies for transplant-ineligible patients
- First-line therapy optimization
Their work addresses the unique therapeutic needs of distinct patient populations within the multiple myeloma spectrum.
Treatment Response Assessment
The investigator evaluates therapeutic outcomes through advanced monitoring techniques, including minimal residual disease assessment and progression-free survival analysis.
- Response monitoring methodologies
- Long-term outcome assessment
- Treatment resistance patterns
Their research incorporates sophisticated evaluation methods to track treatment efficacy and disease progression.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.